Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 83Unknown 24Terminated 12Active not recruiting 5Withdrawn 3Recruiting 3Suspended 2Not yet recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 4Breast 2

Conditions

Breast Neoplasms 2

Interventions

Paclitaxel 4Specimen Handling 3Magnetic Resonance Spectroscopy 3Trastuzumab 2Taxes 2Tamoxifen 2Interleukin-2 2Fluorouracil 2Cyclophosphamide 2Anastrozole 2trastuzumab biosimilar HLX02 1tivozanib 1taletrectinib 1palbociclib 1fluzoparib 1exemestane 1eribulin 1binimetinib 1atezolizumab 1aldesleukin 1Tomography, Optical Coherence 1Testosterone Propionate 1Testosterone 1Tablets 1Receptors, Chimeric Antigen 1Radiotherapy 1PF-05280014 1Ontruzant 1Ogivri 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Suspended × Fluorouracil × Breast × Clear all
NCT02897050 2022-04-20

Trial of Neoadjuvant Docetaxel ± Metronomic Capecitabine/CTX Followed by FEC in Women With Operable Triple Negative Breast Cancer

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 2 Suspended
170 enrolled
Breast

Breast Neoplasms

NCT00002696 2013-08-02

Combination Chemotherapy in Treating Women With Stage III Breast Cancer

National Cancer Institute (NCI)

Phase 3 Suspended
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡